---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-007022"
form_type: "8-K"
ticker: "INBP"
cik: "0001016504"
company_name: "INTEGRATED BIOPHARMA INC"
filed_at: "2023-03-17T23:59:59+00:00"
generated_at: "2026-06-17T23:25:33.147014+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Integrated BioPharma amends credit agreement to replace LIBOR with Term SOFR plus 0.10%

## Summary
- Fourth Amendment to Revolving Credit, Term Loan and Security Agreement dated March 16, 2023.
- Interest rate benchmark changed from LIBOR to Term SOFR Rate plus a 10 basis point SOFR Adjustment.
- Outstanding LIBOR-based loans may remain until their term; new requests use Term SOFR.
- As of March 16, 2023, no outstanding borrowings or pending requests under the agreement.
- Amendment involves Integrated BioPharma and its subsidiaries with PNC Bank as agent.

## SEC filing metadata
- accession: 0001437749-23-007022
- form_type: 8-K
- ticker: INBP
- cik: 0001016504
- company_name: INTEGRATED BIOPHARMA INC
- filed_at: 2023-03-17T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1016504/000143774923007022/0001437749-23-007022-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1016504/000143774923007022/inbp20230316_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-007022
- JSON: https://secwatch.observer/filing/0001437749-23-007022.json
- Plain text: https://secwatch.observer/filing/0001437749-23-007022.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.